Inspire Medical Systems, Inc.

NYSE:INSP Stock Report

Market Cap: US$7.0b

Inspire Medical Systems Balance Sheet Health

Financial Health criteria checks 6/6

Inspire Medical Systems has a total shareholder equity of $572.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $676.8M and $104.3M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$460.38m
EquityUS$572.51m
Total liabilitiesUS$104.30m
Total assetsUS$676.81m

Recent financial health updates

Recent updates

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Inspire Medical nears eight-month high as KeyBanc issues bullish call

Dec 13

Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy

Oct 26

Inspire Medical Systems: Sleep Apnea Value Delivery Pocket

Oct 13

Inspire Medical Systems prices 1M of stock offering at $215.00/share

Aug 12

Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M

Aug 02

Inspire Medical gets FDA nod for full-body MRI compatibility with Inspire therapy

Jul 06

Inspire Medical Systems Priced Low In Past-Year Repeated Range

May 12

Inspire Medical Systems (NYSE:INSP) Has Debt But No Earnings; Should You Worry?

May 01
Inspire Medical Systems (NYSE:INSP) Has Debt But No Earnings; Should You Worry?

Financial Position Analysis

Short Term Liabilities: INSP's short term assets ($593.7M) exceed its short term liabilities ($78.1M).

Long Term Liabilities: INSP's short term assets ($593.7M) exceed its long term liabilities ($26.2M).


Debt to Equity History and Analysis

Debt Level: INSP is debt free.

Reducing Debt: INSP has no debt compared to 5 years ago when its debt to equity ratio was 15.2%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable INSP has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: INSP is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 18% per year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.